EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bone Pain Is Associated with Short Radiographic Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer

Aykut Özmen iD, Caner Kapar iD, İlkay Gültürk iD, Selçuk Şahin, Kamil Gökhan Şeker, Volkan Tuğcu, Deniz Tural

Journal of Clinical Medicine · 21.05.2026 · 15 (10) · 3968

DOI: 10.3390/jcm15103968 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.05.2026. Verfasst von Aykut Özmen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Turkey. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to evaluate the prognostic significance of bone pain at presentation in metastatic castration-sensitive prostate cancer (mCSPC) and its association with radiographic progression-free survival (rPFS), independent of established prognostic factors.

Methods

We retrospectively analyzed 205 patients with mCSPC treated at our center. Data were obtained from patient files and hospital records. rPFS was estimated using the Kaplan–Meier method and compared using the log-rank test. Baseline characteristics according to bone pain status were compared using the χ2 test for categorical variables and the Wilcoxon test for continuous variables.

Results

Median rPFS for the entire cohort was 23.8 months (95% CI: 18.6–29.0). In univariate analysis, median rPFS was significantly shorter in patients with bone pain compared to those without (16.9 vs. 29.5 months, p < 0.001). Other factors associated with worse rPFS included ECOG PS ≥ 1, DNA repair mutations, high disease volume, liver metastasis, hemoglobin < 12 g/dL, and albumin < 3.5 g/dL. In multivariate analysis, bone pain (HR = 2.37, 95% CI: 1.29–4.34; p = 0.005), albumin < 3.5 g/dL (HR = 1.99; p = 0.034), hemoglobin < 12 g/dL (HR = 2.00; p = 0.005), and liver metastasis (HR = 3.07; p = 0.024) remained independent predictors of shorter rPFS.

Conclusions

Bone pain at presentation is an independent prognostic factor for shorter rPFS and may help guide risk stratification and treatment decisions in mCSPC.

Schlagwörter

Stichwörter der Autor:innen

bone painprognostic factorsprostate cancerradiographic progression-free survival

Autor:innen und Institutionen

  • Department of Medical Oncology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Turkey.
  • Department of Medical Oncology, Bakirköy Research and Education Hospital, Istanbul 34140, Turkey.
  • Department of Medical Oncology, Istanbul Research and Education Hospital, Istanbul 34098, Turkey.
  • Urology Department, Istinye University, Istanbul 34010, Turkey.
  • Department of Medical Oncology, Koç University Hospital, Istanbul 34010, Turkey.

ORCID-Profile: Aykut Özmen, Caner Kapar, İlkay Gültürk

Zitieren

APA

Özmen, A., Kapar, C., Gültürk, İ., Şahin, S., Şeker, K. G., Tuğcu, V., & Tural, D. (2026). Bone Pain Is Associated with Short Radiographic Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer. Journal of Clinical Medicine, 15(10), 3968. https://doi.org/10.3390/jcm15103968

Vancouver

Özmen A, Kapar C, Gültürk İ, Şahin S, Şeker KG, Tuğcu V, et al. Bone Pain Is Associated with Short Radiographic Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer. Journal of Clinical Medicine. 2026;15(10):3968. doi:10.3390/jcm15103968

BibTeX
@article{zmen2026,
  author = {Özmen, Aykut and Kapar, Caner and Gültürk, İlkay and Şahin, Selçuk and Şeker, Kamil Gökhan and Tuğcu, Volkan and Tural, Deniz},
  title = {Bone Pain Is Associated with Short Radiographic Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {3968},
  doi = {10.3390/jcm15103968}
}
Kostenlos starten →